Inhibition of PRMT5 moderately suppresses prostate cancer growth in vivo but enhances its response to immunotherapy
-
Published:2024-10
Issue:
Volume:602
Page:217214
-
ISSN:0304-3835
-
Container-title:Cancer Letters
-
language:en
-
Short-container-title:Cancer Letters
Author:
He Qinju,
Zhang YuanzhenORCID,
Li Wenchao,
Chen Saisai,
Xiong Jiangling,
Zhao Ruizhe,
Yuan Kai,
Hu Qiang,
Liu Song,
Gao Guozhen,
Bedford Mark T.,
Tang Dean G.,
Xu BinORCID,
Zou ChengORCID,
Zhang Dingxiao